2026 Half-Year Results

  • Revenue of €22.3 million, impacted by a reduction in production rates in the Industries segment;
  • Half-year operating performance primarily impacted by the Industries division;
  • Update on going concern and preferred strategic options.

Read the press release (in French)


Number of shares and voting rights as at 30/09/2026

Europlasma declares the number of voting rights and shares comprising its share capital as at 30th September.

Read the press release (in French)


Number of shares and voting rights as at 31/08/2026

Europlasma declares the number of voting rights and shares comprising its share capital as at 31st August.

Read the press release (in French)